ArticlePloS one2026
Predicting ankylosing spondylitis disease activity via patient-reported outcome measures: Building prediction models based on machine learning.
Article in PloS one, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveDisease activity is a critical indicator for monitoring the progression of ankylosing spondylitis (AS), guiding clinical decision-making, and informing treatment plans. Patient-reported outcome measures (PROMs) have gained prominence in AS clinical management. However, their potential to predict Ankylosing Spondylitis Disease Activity Score-C-reactive protein (ASDAS-CRP) remains unexplored. This study employs machine learning (ML) techniques to develop prediction models utilizing PROMs data to estimate disease activity in patients with AS.
methodsWe utilized data from 389 patients with AS were included sourced from the China Rheumatoid Arthritis Registry of Patients with Chinese Medicine (CERTAIN) from March 2022 to March 2024. This dataset was divided into a training set (80%) and a testing set (20%). A total of 34 variables, including clinician-recorded features and PROMs (e.g., BASDAI, BASFI, BASMI, PGA, VAS, ASAS-HI, FACIT-F, DASS-21), were employed for feature selection and assessment of feature significance using a variety of machine learning methods. Ten models were constructed using Support Vector Machine (SVM) and K-Nearest Neighbour (KNN) classifiers in conjunction with five feature selection methods: Feature Selection with Orthogonal Regression (FSOR), Trace Ratio Criterion (TRC), Robust Feature Selection (RFS), Pearson Correlation Coefficient (PCC), and ReliefF. Model performance was evaluated based on accuracy, specificity, sensitivity, and area under the receiver operating characteristic curve (AUC-ROC).
resultsA total of 389 patients with AS were included in the analysis. Key characteristics assessed included Patient Global Assessment (PGA), age, and the impact of disease on daily activities. The results indicated that the FSOR+SVM model achieved the best overall performance, with an AUROC of 0.930 (95%CI: 0.87-0.99) in the validation set. Meanwhile, FSOR+SVM also exhibited the highest sensitivity (83.78%), accuracy (79.35%), and specificity (90.50%).
conclusionThe machine learning model developed from PROMs data proved effective for predicting AS disease activity, showing strong agreement with clinical ASDAS-CRP measures.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.